New Year’s is receding fast in the rearview mirror. And for many of us, our sincere resolutions about losing weight and ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...

Myristamide enhances cognitive function and BDNF in mice, indicating Camembert cheese's potential in combating cognitive ...

A continuous "prevention and control system for dementia, covering prevention, screening, diagnosis, treatment, rehabilitation and care, will be established by 2030", Xinhua said. The growth of ...

It is designed to be used with people living with advanced dementia within a care home who do not have a formal diagnosis. In these cases a referral to memory services may not be feasible or desirable ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer ... have enduring benefits for later life memory and risk of dementia, according to a new study.

Nootropics are touted as “smart drugs” meant to improve cognitive performance. But there’s a lot we still don’t know about ...

Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by ...